Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer

Management of ovarian cancer still requires improvements in therapeutic options. A drug delivery strategy was tested that allows specific targeting of tumor cells in combination with a controlled release of a cytotoxic molecule. To this aim, the efficacy of a loco-regional intraperitoneal treatment...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncoscience
Auteurs principaux: Montagner, Isabella Monia, Merlo, Anna, Carpanese, Debora, Zuccolotto, Gaia, Renier, Davide, Campisi, Monica, Pasut, Gianfranco, Zanovello, Paola, Rosato, Antonio
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2015
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4468323/
https://ncbi.nlm.nih.gov/pubmed/26097871
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires